Drug Side Effects
Search
DIFFUSE CUTANEOUS MASTOCYTOSIS
DIFFUSE CUTANEOUS MASTOCYTOSIS
was reported 30 times
DIFFUSE CUTANEOUS MASTOCYTOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Glycopeptide Antibacterial [EPC]
13
0.0002
1
Thymic Stromal Lymphopoietin Blocker [EPC]
1
0.0001
2
Quinolone Antimicrobial [EPC]
1
0.0001
3
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
9
0.0001
4
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
9
0.0001
5
Aminoglycoside Antibacterial [EPC]
3
0.0001
6
Nitroimidazole Antimicrobial [EPC]
4
0.0001
7
Leukotriene Receptor Antagonist [EPC]
1
0.0000
8
Provitamin D2 Compound [EPC]
1
0.0000
9
Azole Antifungal [EPC]
5
0.0000
10
Penem Antibacterial [EPC]
1
0.0000
11
Calcineurin Inhibitor Immunosuppressant [EPC]
3
0.0000
12
Anti-IgE [EPC]
2
0.0000
13
Histamine-2 Receptor Antagonist [EPC]
2
0.0000
14
Opioid Agonist [EPC]
4
0.0000
15
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
16
Proton Pump Inhibitor [EPC]
2
0.0000
17
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
18
Benzodiazepine [EPC]
2
0.0000
19
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
20
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
21
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
22
Kinase Inhibitor [EPC]
1
0.0000
23
Corticosteroid [EPC]
1
0.0000